Published in Ann Neurol on December 01, 2010
Genetic and Environmental Risk Factors for Hemorrhagic Stroke-GERFHS III (GERFHS-III) | NCT00930280
Alzheimer's disease: the challenge of the second century. Sci Transl Med (2011) 4.88
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol (2013) 4.16
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage. JAMA (2015) 2.19
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol (2011) 1.47
Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke (2014) 1.32
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet (2014) 1.20
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke (2012) 1.19
Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings. Neuroradiology (2013) 1.17
Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke (2014) 1.15
APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis. Neurology (2013) 1.14
Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol (2012) 1.14
Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol (2012) 1.14
Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology (2012) 1.06
Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke (2013) 1.02
Genetic associations with brain microbleeds: Systematic review and meta-analyses. Neurology (2011) 0.97
Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage. Stroke (2012) 0.96
APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol (2013) 0.96
Genetics of cerebral small vessel disease. J Stroke (2015) 0.93
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. J Neurol Neurosurg Psychiatry (2013) 0.93
Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology (2014) 0.92
Stroke genetics: a review and update. J Stroke (2014) 0.91
APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhage. Neurol Genet (2016) 0.91
Intracerebral hemorrhage in the oldest old: a population-based study (vantaa 85+). Front Neurol (2012) 0.89
Treatment targets in intracerebral hemorrhage. Neurotherapeutics (2011) 0.89
Burden of blood pressure-related alleles is associated with larger hematoma volume and worse outcome in intracerebral hemorrhage. Stroke (2013) 0.88
Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage. Stroke (2013) 0.86
Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. JAMA Neurol (2013) 0.86
Therapeutic strategies in acute intracerebral hemorrhage. Neurotherapeutics (2012) 0.85
APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging (2015) 0.84
TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer's Disease. Transl Stroke Res (2012) 0.83
Delayed seizures after intracerebral haemorrhage. Brain (2016) 0.83
Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data. Eur J Hum Genet (2014) 0.82
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami. J Cereb Blood Flow Metab (2015) 0.82
Genetic factors in cerebral small vessel disease and their impact on stroke and dementia. J Cereb Blood Flow Metab (2016) 0.81
Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease. Acta Neuropathol (2016) 0.81
Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease. BMC Nephrol (2014) 0.81
APOE ε variants increase risk of warfarin-related intracerebral hemorrhage. Neurology (2014) 0.80
Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease. PLoS One (2015) 0.80
APOE ε4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage. Neurology (2015) 0.80
Predicting symptomatic intracerebral hemorrhage versus lacunar disease in patients with longstanding hypertension. Stroke (2014) 0.80
Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies. Lipids Health Dis (2014) 0.79
Association of the APOE, MTHFR and ACE Genes Polymorphisms and Stroke in Zambian Patients. Neurol Int (2013) 0.78
Stroke Genetics Update: 2011. Curr Cardiovasc Risk Rep (2011) 0.78
Genetic risk factors for spontaneous intracerebral haemorrhage. Nat Rev Neurol (2015) 0.77
Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies? Curr Cardiol Rep (2013) 0.77
Advances in genetics 2010. Stroke (2011) 0.77
Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis). PeerJ (2014) 0.77
Genetic Risk Factors for Ischemic and Hemorrhagic Stroke. Curr Cardiol Rep (2016) 0.76
Apolipoprotein E polymorphism and the risk of intracranial aneurysms in a Chinese population. BMC Neurol (2016) 0.76
Rare Coding Variation and Risk of Intracerebral Hemorrhage. Stroke (2015) 0.76
Oral Cnm-positive Streptococcus Mutans Expressing Collagen Binding Activity is a Risk Factor for Cerebral Microbleeds and Cognitive Impairment. Sci Rep (2016) 0.75
Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic Features. Front Aging Neurosci (2016) 0.75
Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis. Sci Rep (2017) 0.75
Intracerebral haemorrhage: understanding racial differences in intracerebral haemorrhage. Nat Rev Neurol (2013) 0.75
Clinical neurogenetics: stroke. Neurol Clin (2013) 0.75
Use of MRI for Risk Stratification in Anticoagulation Decision Making in Atrial Fibrillation: Promising, but More Data are Needed for a Robust Algorithm. Front Neurol (2014) 0.75
Intracranial hemorrhage. Emerg Med Clin North Am (2012) 0.75
The MTHFR C677T Polymorphism and Risk of Intracerebral Hemorrhage in a Chinese Han Population. Med Sci Monit (2016) 0.75
Warfarin and statins are associated with hematoma volume in primary infratentorial intracerebral hemorrhage. Neurocrit Care (2014) 0.75
Resumption of Anticoagulation After Intracranial Hemorrhage. Curr Treat Options Neurol (2017) 0.75
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet (2007) 12.13
Spontaneous intracerebral hemorrhage. N Engl J Med (2001) 8.60
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 4.26
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol (1995) 3.60
Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 3.43
Genome-wide significance for dense SNP and resequencing data. Genet Epidemiol (2008) 3.26
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science (1994) 2.98
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 2.92
Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol (2010) 2.76
Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke (1997) 2.38
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci (1999) 2.15
Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg (2002) 1.72
Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J Biol Chem (1999) 1.64
Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem (1995) 1.61
APOE distribution in world populations with new data from India and the UK. Ann Hum Biol (2006) 1.59
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol (2000) 1.35
Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem (2002) 1.29
ApoE isoform affects LTP in human targeted replacement mice. Neuroreport (2004) 1.24
APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology (2008) 1.24
Exploiting common genetic variation to make anticoagulation safer. Stroke (2009) 1.13
Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur J Neurol (2009) 1.09
Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage. Ann N Y Acad Sci (2000) 1.08
Glutathione peroxidase 1 C593T polymorphism is associated with lobar intracerebral hemorrhage. Cerebrovasc Dis (2008) 0.99
The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS One (2008) 0.98
Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand (2000) 0.96
Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population. Cerebrovasc Dis (2006) 0.95
ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy. Neurobiol Aging (2010) 0.91
Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol (2001) 0.89
Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. J Neurogenet (2004) 0.83
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Global variation in copy number in the human genome. Nature (2006) 57.50
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
International network of cancer genome projects. Nature (2010) 20.35
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Transcriptome and genome sequencing uncovers functional variation in humans. Nature (2013) 8.89
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Genome assembly comparison identifies structural variants in the human genome. Nat Genet (2006) 6.93
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet (2011) 6.43
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol (2007) 4.68
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38
Genome-wide detection of segmental duplications and potential assembly errors in the human genome sequence. Genome Biol (2003) 4.32
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet (2007) 3.98
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology (2015) 3.73
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol (2004) 3.69
Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke (2005) 3.67
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology (2012) 3.62
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med (2007) 3.61
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol (2002) 3.54
SNPassoc: an R package to perform whole genome association studies. Bioinformatics (2007) 3.52
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Genetic structure of Europeans: a view from the North-East. PLoS One (2009) 3.46
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med (2009) 3.44
Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 3.43
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke (2008) 3.40
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke (2007) 3.34